Book soon for funded Meningitis vaccines 3 months prior to starting Uni or boarding school Criteria: Individuals aged 13–25 years, inclusively:
Bexsero and MenQuadfi are recommended and funded for those who are entering within the next three months or are in their first year of living in boarding school hostels, tertiary education halls of residence, military barracks, Youth Justice residences or prisons.
Funding covers individuals who turn 13 years of age while living in boarding school hostels.
If it feels appropriate you may book a virtual appointment ( phone or video) via portal, but not onsite. If you think you likely need to be seen, then please phone reception and our nurses will triage so we can time appointments via our back door access. This is not just about covid but all viral illnesses!
It is essential that we keep our waiting room and Practice safe for vulnerable patients & minimize risk of our staff getting ill.
INFLUVAC is the 2024 Funded Flu Vaccine which is FREE for patients who meet the Eligibility criteria*. The cost, for patients who are not eligible for a funded vaccine, is $38.00.
– If you are wanting a flu vaccine only, simply come in, or please make a Nurse Appointment if you prefer a specific time. – If you would like to have the new Covid booster at the same time as the flu vaccine, please make a Nurse Appointment.
Other non-funded vaccines available… There are two ‘advanced’ flu vaccines available from Wednesday 6th March:
1. The 2024 ‘Advanced flu vaccine’, FLUCELVAX Quad is for patients aged between 6 months and 64 years – cost $45.00. 2. The 2024 ‘Advanced flu vaccine’, FLUAD Quad is for patients aged 65 years and over – cost $50.00.
Phone reception for a vaccine appointment at a time to suit you on 09 5215128
Further booster dose in late 2023
COVID-19 has not yet become a seasonal infection in New Zealand. The risk continues all year.
Consider a further booster dose in late 2023 (regardless of the number of previous booster doses) if both of the following apply:
It has been at least 6 months since the patient’s last COVID-19 booster, recovery from a COVID-19 infection, or positive COVID-19 test if asymptomatic
The patient is at increased risk of severe disease or long-term consequences from COVID-19 infection:
Aged 75 years or older
Aged 16 years or older with severe immunocompromise. These people were eligible for a third primary dose.
Māori or Pacific ethnicity and aged 65 years or older
Aged 30 years or older with complex health needs that increase their risk of frailty (deterioration of their independence if they become mildly unwell). These people often live in residential care.
For Uni students aged 13-25yrs : Please make an appointment with the Nurse within 3 months of leaving for Uni, this allows timing for the 2 nd dose 1 month after the 1st . Please see the vaccines below that are time sensitive for eligibility: Meningococcal B vaccine Until 31 August 2025
Up to three doses of MenB (Bexsero) (dependent on age at first dose) are funded for a catchup programme for all children under 59 months of age (inclusive).
Two doses for individuals aged 13-25 who are entering within the next three months, or in their first year of living in boarding school hostels, tertiary education halls of residence, military barracks, or prisons.
Until 28 February 2024 – Two doses for individuals aged 13-25 who are currently in their second, third or more years of living in boarding school hostels, tertiary education halls of residence, military barracks, or prisons. Meningococcal A, C, Y, W vaccine
Adolescents and young adults aged 13-25 years inclusively, who are entering within the next 3 months, or are in their first year of living in a boarding school hostel, tertiary education halls of residence, military barrack, or prison
Measles is a serious viral disease that can make people very sick. It can spread very easily among people who have not had the Measles, Mumps, Rubella (MMR) vaccine or had measles before.
You are considered immune to measles if you: • Were born before 1 Jan 1969 • Have had measles before • Have had two MMR vaccinations, and the last dose was over a month ago. • Babies under 15 months are considered immune if they have had one MMR dose after 12 months of age, given at least a month ago • Have had a blood test showing you are immune
If you have measles symptoms, such as a fever and a rash, you should seek medical advice urgently. Call your doctor or ring Healthline for free anytime on 0800 611 116.
Please do not visit a medical centre or hospital without calling first as you may risk passing on the virus to others.
Bexsero (meningococcal group B) is funded on the National Immunisation Schedule, and catchup programmes are available for all under 5-year-olds, adolescents, and young adults.
• catch up for 13 months to 59 monthsavailable until 31 August 2025 – for those tamariki who were aged under 5 years on 1 March 2023, but have since turned 5 years of age, are eligible for the catch-up programme.
* Individuals who are aged 13 – 25 years who are already in close-living, such as boarding school hostels and university halls of residence, only have until 28/2/24 to receive funded Bexsero as part of the catch-up program
